AU2882592A - Methods for treatment of hyperlipidemia using azaspiranes - Google Patents

Methods for treatment of hyperlipidemia using azaspiranes

Info

Publication number
AU2882592A
AU2882592A AU28825/92A AU2882592A AU2882592A AU 2882592 A AU2882592 A AU 2882592A AU 28825/92 A AU28825/92 A AU 28825/92A AU 2882592 A AU2882592 A AU 2882592A AU 2882592 A AU2882592 A AU 2882592A
Authority
AU
Australia
Prior art keywords
azaspiranes
hyperlipidemia
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28825/92A
Other languages
English (en)
Inventor
Peter John Bugelski
William David Kerns
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2882592A publication Critical patent/AU2882592A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AU28825/92A 1991-10-25 1992-10-15 Methods for treatment of hyperlipidemia using azaspiranes Abandoned AU2882592A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919122735A GB9122735D0 (en) 1991-10-25 1991-10-25 Methods
GB9122735 1991-10-25

Publications (1)

Publication Number Publication Date
AU2882592A true AU2882592A (en) 1993-05-21

Family

ID=10703563

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28825/92A Abandoned AU2882592A (en) 1991-10-25 1992-10-15 Methods for treatment of hyperlipidemia using azaspiranes

Country Status (10)

Country Link
US (1) US5395848A (cg-RX-API-DMAC7.html)
EP (1) EP0609358A4 (cg-RX-API-DMAC7.html)
JP (1) JPH07500340A (cg-RX-API-DMAC7.html)
AU (1) AU2882592A (cg-RX-API-DMAC7.html)
GB (1) GB9122735D0 (cg-RX-API-DMAC7.html)
MX (1) MX9206135A (cg-RX-API-DMAC7.html)
PT (1) PT101003A (cg-RX-API-DMAC7.html)
TW (1) TW221029B (cg-RX-API-DMAC7.html)
WO (1) WO1993007869A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA928198B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482959A (en) * 1992-01-28 1996-01-09 Smithkline Beecham Corporation Method for delaying aids in an HIV infected individual by administration of substituted azaspirane compounds
GB9308780D0 (en) * 1993-04-28 1993-06-09 Smithkline Beecham Corp Methods
US5708019A (en) * 1993-04-28 1998-01-13 Smithkline Beecham Corporation Methods of treating hyperlipidemia using azaspirane derivatives
NZ286951A (en) * 1995-07-13 1998-02-26 Anormed Inc Substituted Under N-n-diethyl-8,8-dipropyl-2-azaspiro[4,5]decane-2-propanamine dimaleate
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato
GB2309167A (en) * 1997-05-10 1997-07-23 Anormed Inc The use of azaspiranes in the treatment of Alzheimer's disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291030A (en) * 1980-07-25 1981-09-22 Unimed, Inc. Method of lowering blood cholesterol
DE3522578A1 (de) * 1984-06-26 1986-01-02 Ciba-Geigy Ag, Basel Spiroverbindung und verfahren zu ihrer herstellung
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes

Also Published As

Publication number Publication date
TW221029B (cg-RX-API-DMAC7.html) 1994-02-11
EP0609358A4 (en) 1994-10-12
ZA928198B (en) 1993-12-17
GB9122735D0 (en) 1991-12-11
EP0609358A1 (en) 1994-08-10
MX9206135A (es) 1993-08-01
PT101003A (pt) 1994-01-31
US5395848A (en) 1995-03-07
WO1993007869A1 (en) 1993-04-29
JPH07500340A (ja) 1995-01-12

Similar Documents

Publication Publication Date Title
AU2300092A (en) Prostaglandin e2 treatment of impotence
AU5268696A (en) Novel compounds and methods for therapy
AU618231B3 (en) Treatment of emulsions
AU3007492A (en) Treatment of wastewater
AU626005B1 (en) Treatment of endometriosis
AU6560494A (en) Water treatment apparatus
AU3730093A (en) Methods of treating diabetes
HK88695A (en) Massaging apparatus
AU2649092A (en) Desulphurisation treatment
AU2685892A (en) Method of treating blood
AU2882592A (en) Methods for treatment of hyperlipidemia using azaspiranes
AU4220193A (en) Deazaaminopterins for treatment of inflammation
AU3473193A (en) Treatment for atherosclerosis
AU2875092A (en) Methods for the treatment of hyperlipidemia using azaspiranes
AU1175692A (en) Effluent treatment
AU3279993A (en) A device for the treatment/purification of sewage-effluent
HK1012273A (en) Methods for treatment of hyperlipidemia using azaspiranes
AU1604692A (en) Treatment of longitudinally extending members
AU1593792A (en) Treatment of mastitis
AU8266691A (en) Method of disinfection
HK1007936B (en) Method of disinfection
AU1176092A (en) Process for preparation of 4-alkylsulfonyl-1-alkyl-2-chlorobenzenes and similar compounds
AU5699594A (en) Use of alkylthiopyridines for controlling helicobacter bacteria
RU2003311C1 (ru) Способ блефарораффии
AU645182B2 (en) Process for the preparation of N-alkylsufonamides